Navigation Links
Intrinsic Enrolls First Patient in Barricaid® Trial
Date:2/17/2011

WOBURN, Mass., Feb. 17, 2011 /PRNewswire/ -- Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus closure devices, announced today that it has enrolled the first patient, December 17, 2010, in a Randomized Clinical Trial of its Barricaid® device. Barricaid is designed to prevent reherniations following lumbar discectomy, while allowing the surgeon to retain as much of the native nucleus as possible preserving normal disc height and biomechanics. Barricaid accomplishes this by providing the added security of a bone-anchored device that can be used to close larger anular defects or in cases where anular integrity is in question.

The procedure was performed by Guido Dua, M.D., Chief of Neurosurgery, Middelheim Hospital in Antwerp, Belgium. Robert Hes, MD, Principal Investigator at Middelheim, stated, "What I like about the Barricaid device is that it provides an elegant solution to possible reherniation. Barricaid allows for a limited discectomy while offering the potential for secure closure of the anular defect and a reduction in both the risk of recurrent disc herniation and disc height loss.  I was very satisfied with the simplicity and ease of the procedure. I anticipate that we will be able to recreate the outstanding results seen in prior Barricaid studies."

"We are pleased to have begun our randomized study in Europe," said Noel Rolon, Intrinsic Vice President, Regulatory and Clinical Affairs. "The fact that we have started enrolling patients so quickly indicates the level of enthusiasm among our investigators.  It is clear that the positive clinical and commercial results recently presented at the DWG meeting in Bremen and published in the November 2010 issue of the European Spine Journal, provide a strong foundation for this post-marketing study."

Intrinsic is enrolling up to 800 patients in a prospective, randomized, superiority study comparing Barricaid to traditional limited discectomy. "We are exc
'/>"/>

SOURCE Intrinsic Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Intrinsic Bioprobes Announces Issuance of US Patent for Novel Biomarkers and Assays for Myocardial Infarction
2. Micell Technologies Enrolls First Patient in CE Mark DESSOLVE II Study of MiStent™ Drug-Eluting Coronary Stent (DES)
3. Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C
4. Cardiogenesis Enrolls First Two Patients in Its Feasibility Study of the PHOENIX® Combination Delivery System
5. Omeros Enrolls First Patient in Phase 2b Clinical Trial Evaluating OMS302 in Patients Undergoing Cataract Surgery
6. BHR Pharma Enrolls First Patient in Phase 3 SyNAPSe Traumatic Brain Injury Trial
7. Crux Biomedical Enrolls First Patient in Its Retrieve 2 U.S. Pivotal Trial
8. Ophthotech Enrolls Its First Patient in a Randomized, Controlled Phase II Study of E10030 in Macular Degeneration
9. PARI Pharma Enrolls First Patient in Phase 2b Study of L-CsA
10. Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland
11. Facet Solutions Enrolls 100th Patient in US Pivotal IDE Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 Former NASA scientist ... last week where he discussed Theradome™, the first portable ... The FOX segment shows firsthand how, via laser technology, ... loss solution that will not require surgery or medication.  ... at the base of the hair follicle, which is ...
(Date:5/4/2015)... and TORONTO , May 4, ... (OTCQB:GNBT) today announced that it intends to dividend to ... upon completion of a definitive licensing agreement to license ... ( www.smoofi.com ) (OTCQB:SMFI). As announced on ... of intent in respect of the licensing of its ...
(Date:5/4/2015)...  Impax Laboratories, Inc. (NASDAQ: IPXL ) announced ... appointing  Donna M. Hughes, as Senior Vice President, Human ... Vice President, Chief Compliance Officer. Both Ms. Hughes and ... Executive Officer, Fred Wilkinson . "We ... Impax team," said Fred Wilkinson , President and ...
Breaking Medicine Technology:FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 3Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 4Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 5Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 3
... on complex cases, facility called ,future of hospital care, ... announces the opening of the Hamon Tower, the largest expansion ... intensive care for the region,s most critically ill patients. , ... new clinical programs for ICU patients, Hamon Tower is designed ...
... IRVINE, Calif., Oct. 2 ISTA Pharmaceuticals, Inc. (Nasdaq: ... financial results after market close on November 3, 2009. In ... p.m. Eastern Time to discuss these results and provide a ... , Time: 5:00 p.m. Eastern Time , Conference call ...
Cached Medicine Technology:Hamon Tower Features Critical Care Advances, Potential for Reduced Costs 2
(Date:5/5/2015)... “We currently have larger size casual sun hats that work ... “We felt it was time to address the issue that ... in an extra large size that they can wear to the ... hats such as the Rebecca, Chloe, Stevie Fedora and the ... extra large size , fitting heads that measure up to ...
(Date:5/4/2015)... Parlin, New Jersey (PRWEB) May 04, 2015 ... contest to give a chance to more youths to participate ... to encourage youths in her area to do good deeds ... behavior, Dr.Blagoev intends to empower their minds and teach them ... The contest is accessible to any youth 18 years of ...
(Date:5/4/2015)... 05, 2015 The National Association ... Doherty as a 2015-2016 inductee into the NAPW ... with this prestigious distinction for leadership in healthcare. NAPW ... women, boasting more than 700,000 members and over 200 ... into this exceptional group of professional women,” says NAPW ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 During 2015-2019, ... a 7.7% CAGR. Currently, the European and APAC probiotic ... while the North American probiotic market lags behind owing ... population. , The North American probiotic market is ... 58%), followed by Canada and Mexico. The North American ...
(Date:5/4/2015)... 2015 Leonardo J. Lozada, M.D., Saint ... executive, and William C. Daniel, M.D., Saint Luke’s Health ... invitations from the Secretary of the Air Force to ... the Air War College, Maxwell Air Force Base, Alabama. ... to senior U.S. and international officers and their civilian ...
Breaking Medicine News(10 mins):Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Launches Their New Extra Large Size Fashion Sun Hats Collection 2Health News:10 More Days To Enter Good Deed Contest 2Health News:National Association of Professional Women Inducts Jennifer Yates Doherty, Owner of Palmetto Rehabilitation Services, LLC, into its 2015 VIP Woman of the Year Circle 2Health News:North America Probiotic Market to Increase by 2019, Announces MicroMarketMonitor in Its New Research Report Recently Published at MarketPublishers.com 2Health News:Saint Luke’s Health System Leadership Selected to Attend National Security Forum 2
... LONG BEACH, Calif., July 31, 2009 Raytheon ... patient tracking system to a public health-led team of first ... improve the availability of patient information. , ... the triage, treatment and transport of victims during mass casualty ...
... relieve stress, personal troubles, researchers caution, , FRIDAY, July ... Americans now have a positive opinion on psychiatric medications, ... of six people surveyed felt psychiatric medications could help ... medications could help people deal with day-to-day stresses, help ...
... LAWRENCE, Mass., July 31 NxStage Medical, Inc. (Nasdaq: ... today announced that Jeffrey H. Burbank, Chief Executive Officer, will be ... 11, 2009 at the InterContinental Hotel, Boston, MA. , ... 11th at 10:00 a.m. (EST). To listen to the audio ...
... EDWARDSVILLE, Ill., July 31 With the health care debate heating up in ... America might want to take a page from the Swiss playbook. , ... Switzerland has a mandate requiring everyone to be covered by ... to meet the mandate. , There is no employer-provided ...
... , , , SILVER SPRING, ... announced its results of operations for the quarter ended June 30, 2009. ... 2009 were $84.0 million, up from $68.6 million for the second quarter of ... share, for the second quarter of 2009, compared to net income of $12.1 ...
... ... Moran and Todd Tiahrt today released the following statement regarding the Government Accountability Office,s report ... research can be conducted as safely on the mainland as on Plum Island. , ... Washington, DC (Vocus) July 31, 2009 ...
Cached Medicine News:Health News:Raytheon to Provide California First Responders and Healthcare Personnel Electronic Patient Tracking System 2Health News:Psych Drugs Gaining Widespread Acceptance 2Health News:Psych Drugs Gaining Widespread Acceptance 3Health News:NxStage to Present at the Canaccord Adams Global Growth Conference 2Health News:Do the Swiss Have the Answer to America's Health Care Dilemma? 2Health News:Do the Swiss Have the Answer to America's Health Care Dilemma? 3Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 2Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 3Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 4Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 5Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 6Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 7Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 8Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 9Health News:Kansas Delegation: GAO Report Short on Expertise, Long on Errors; NBAF Critical to Protect Nation's Food Supply 2
... the only in-office test approved by the FDA ... BladderChek Test is a painless and non-invasive assay, ... elevated levels of NMP22 protein. Healthy individuals generally ... the urine. However, the level of NMP22 protein ...
Used for measuring rectal pressure during urodynamic studies. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open pack...
Used for suprapubic monitoring of bladder pressures. Suprapubic urodynamic studies avoid the effects of urethral catheterization and eliminate the need for a double bladder puncture. Supplied sterile...
... point-of-care (POC) diagnosis of patients with acute ... embolism. For use in doctors offices or ... counts, the Cardiac reader analyzer allows the ... D-Dimer from a single whole blood sample ...
Medicine Products: